Find a Specialist | Contact Us | For Healthcare Professionals

REMICADE and Pediatric Crohn's Disease

Explaining REMICADE to Your Child

Pediatric Crohn's Disease Clinical Study

REACH Clinical Study

What Parents Should Know

Living with Pediatric Crohn's

For Kids with Crohn's

Please read the Medication Guide for REMICADE and discuss with your doctor.

Pediatric Crohn’s Disease Clinical Study

REMICADE is for children (ages 6-17) with moderate to severe Crohn's disease who haven't responded well to other therapies. REMICADE has been approved for the treatment of pediatric Crohn’s disease, based on the REACH clinical study. To read more about this clinical study and its results, please visit the following resource.

REACH study overview

Medication Guide for REMICADE

Please read the Medication Guide for REMICADE and discuss with your doctor.
(Requires Adobe^® Acrobat^® Reader^®. Click here to download.)

REMICADE Information

Receive the latest news and information from REMICADE. Sign up now.

IMPORTANT SAFETY INFORMATION | Privacy Policy | Legal Notice | Site Map | About Centocor

© Centocor, Inc. 1999-2007
This site is published by Centocor, Inc. which is solely responsible for its contents.
It is intended for residents from the United States.
Last Updated: January 22, 2008